Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 16;10(2):451.
doi: 10.3390/microorganisms10020451.

Literature Review of Omicron: A Grim Reality Amidst COVID-19

Suraj Arora  1 , Vishakha Grover  2 , Priyanka Saluja  3 , Youssef Abdullah Algarni  1 , Shahabe Abullais Saquib  4 , Shaik Mohammed Asif  5 , Kavita Batra  6 , Mohammed Y Alshahrani  7 , Gotam Das  8 , Rajni Jain  9 , Anchal Ohri  2
Affiliations
Review

Literature Review of Omicron: A Grim Reality Amidst COVID-19

Suraj Arora et al. Microorganisms. .

Abstract

Coronavirus disease 2019 (COVID-19) first emerged in Wuhan city in December 2019, and became a grave global concern due to its highly infectious nature. The Severe Acute Respiratory Coronavirus-2, with its predecessors (i.e., MERS-CoV and SARS-CoV) belong to the family of Coronaviridae. Reportedly, COVID-19 has infected 344,710,576 people around the globe and killed nearly 5,598,511 persons in the short span of two years. On November 24, 2021, B.1.1.529 strain, later named Omicron, was classified as a Variant of Concern (VOC). SARS-CoV-2 has continuously undergone a series of unprecedented mutations and evolved to exhibit varying characteristics. These mutations have largely occurred in the spike (S) protein (site for antibody binding), which attribute high infectivity and transmissibility characteristics to the Omicron strain. Although many studies have attempted to understand this new challenge in the COVID-19 strains race, there is still a lot to be demystified. Therefore, the purpose of this review was to summarize the structural or virologic characteristics, burden, and epidemiology of the Omicron variant and its potential to evade the immune response.

Keywords: B.1.1.529; COVID-19; Omicron; South Africa; cell-mediated immunity; monoclonal antibodies; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Centers for Disease Control and Prevention Transmission of Coronavirus Disease 2019 (COVID-19) [(accessed on 21 January 2022)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/index.html.
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. Wax R.S., Christian M.D. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can. J. Anesth. 2020;67:568–576. doi: 10.1007/s12630-020-01591-x. - DOI - PMC - PubMed
    1. The Worldometers COVID-19 Coronavirus Pandemic. 2022. [(accessed on 21 January 2022)]. Available online: https://www.worldometers.info/coronavirus/
    1. Centers for Disease Control and Prevention SARS-CoV-2 Variant Classifications and Definitions. [(accessed on 6 December 2021)];2021 Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.

LinkOut - more resources